Erik Holmlin, PhD
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Erik Holmlin is a dynamic leader with more than two decades of experience developing innovative solutions and companies in the life sciences and health care industries.
Erik was a National Institutes of Health postdoctoral fellow at Harvard University and a National Science Foundation predoctoral fellow at the California Institute of Technology, Pasadena (Caltech). He holds a PhD in chemistry from Caltech and MBAs from UC Berkeley and Columbia University.
CHIEF FINANCIAL OFFICER
Mike Ward has more than 20 years of experience in life sciences-dedicated investment banking, venture capital and private equity investments.
Prior to joining Lurie Investment Fund, Mike gained more than 15 years of investment banking experience at Leerink Partners, Credit Suisse, Dresdner Kleinwort Wasserstein, BMO and Vector Securities. During his career in investment banking, Mike executed more than 80 life sciences mergers, acquisitions, divestitures, strategic alliances, private placements, IPOs and follow-on public offerings. In his more than two decades of experience serving and fostering life sciences companies, Mike has focused predominantly on the medical technology, tools, diagnostics and biopharmaceutical markets. Mike received, with summa cum laude distinction, a bachelor’s in finance from the University of Illinois.
CHIEF OPERATING OFFICER
Mark Borodkin has a 20-year history of success in the development of systems for the life sciences and medical device industries.
CHIEF COMMERCIAL OFFICER
Warren Robinson has served as Bionano Genomics’ Chief Commercial Officer since November 2017 and previously served as a Vice President with Bionano in various sales and marketing functions from October 2015 to November 2017, including most recently as our Vice President of Global Sales and Marketing.